MX9201916A - Derivados de 4-aril-3-hetero aril ureido quinolina como agentes antihipercolesterolemicos y antiaterosclerosicos. - Google Patents

Derivados de 4-aril-3-hetero aril ureido quinolina como agentes antihipercolesterolemicos y antiaterosclerosicos.

Info

Publication number
MX9201916A
MX9201916A MX9201916A MX9201916A MX9201916A MX 9201916 A MX9201916 A MX 9201916A MX 9201916 A MX9201916 A MX 9201916A MX 9201916 A MX9201916 A MX 9201916A MX 9201916 A MX9201916 A MX 9201916A
Authority
MX
Mexico
Prior art keywords
aryl
atherosclerosic
ureid
hypercholesterolemic
quinoline
Prior art date
Application number
MX9201916A
Other languages
English (en)
Inventor
Ernest S Hamanaka
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9201916A publication Critical patent/MX9201916A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
MX9201916A 1991-04-26 1992-04-24 Derivados de 4-aril-3-hetero aril ureido quinolina como agentes antihipercolesterolemicos y antiaterosclerosicos. MX9201916A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69232391A 1991-04-26 1991-04-26

Publications (1)

Publication Number Publication Date
MX9201916A true MX9201916A (es) 1992-11-01

Family

ID=24780107

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9201916A MX9201916A (es) 1991-04-26 1992-04-24 Derivados de 4-aril-3-hetero aril ureido quinolina como agentes antihipercolesterolemicos y antiaterosclerosicos.

Country Status (20)

Country Link
EP (1) EP0590094A1 (es)
JP (1) JPH0776215B2 (es)
CN (1) CN1066068A (es)
AU (1) AU1879792A (es)
BR (1) BR9205939A (es)
CA (1) CA2108014A1 (es)
CZ (1) CZ395592A3 (es)
DE (1) DE9290049U1 (es)
FI (1) FI934710A0 (es)
HU (1) HUT65748A (es)
IE (1) IE921330A1 (es)
IL (1) IL101627A0 (es)
MX (1) MX9201916A (es)
NO (1) NO933837L (es)
NZ (1) NZ242493A (es)
PT (1) PT100426A (es)
TW (1) TW197436B (es)
WO (1) WO1992019614A1 (es)
YU (1) YU44592A (es)
ZA (1) ZA922976B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3323393A (en) * 1992-01-23 1993-09-01 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5843957A (en) * 1995-05-19 1998-12-01 Sumitomo Pharmaceuticals Company, Ltd. Naphthyridine derivatives
ATE272635T1 (de) * 1995-05-31 2004-08-15 Sumitomo Pharma Neue naphthyridinderivate.
AU725276B2 (en) * 1996-11-26 2000-10-12 Sumitomo Pharmaceuticals Company, Limited Novel naphthyridine derivatives
EP1086948A4 (en) 1998-02-25 2004-03-10 Sumitomo Pharma PYRIDONE DERIVATIVES AND THEIR MANUFACTURING PROCESS
US6452008B2 (en) 1998-02-25 2002-09-17 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for preparing the same
SV2005001973A (es) 2003-12-12 2005-11-04 Wyeth Corp Quinolinas utiles en el tratamiento de enfermedades cardiovasculares ref. wyth0090-504 (am101500)
CN103601677B (zh) * 2013-11-19 2015-11-18 清华大学 制备2-烷硫基喹啉衍生物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE892088L (en) * 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use
MX22406A (es) * 1989-09-15 1994-01-31 Pfizer Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat).
TW205037B (es) * 1989-10-06 1993-05-01 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
AU1879792A (en) 1992-12-21
JPH06501025A (ja) 1994-01-27
JPH0776215B2 (ja) 1995-08-16
HU9303025D0 (en) 1994-01-28
DE9290049U1 (de) 1994-01-05
WO1992019614A1 (en) 1992-11-12
CA2108014A1 (en) 1992-10-27
IE921330A1 (en) 1992-11-04
EP0590094A1 (en) 1994-04-06
ZA922976B (en) 1993-10-25
IL101627A0 (en) 1992-12-30
PT100426A (pt) 1993-08-31
BR9205939A (pt) 1994-09-27
YU44592A (sh) 1994-12-28
CN1066068A (zh) 1992-11-11
NZ242493A (en) 1994-08-26
FI934710A (fi) 1993-10-25
NO933837L (no) 1993-10-25
FI934710A0 (fi) 1993-10-25
CZ395592A3 (en) 1994-02-16
TW197436B (es) 1993-01-01
HUT65748A (en) 1994-07-28

Similar Documents

Publication Publication Date Title
NO932176L (no) Kinolin-, naftyridin- og pyridobenzoksazinderivater
DE59208263D1 (de) 3-Aryl-4-hydroxy-delta3-dihydrofuranon- und 3-Aryl-4-hydroxy-delta3-dihydrothiophenon-Derivate
DE10299021I1 (de) Piperazinyl-heterocyclische derivate
LV10099A (lv) Bicikliski heterocikliski atvasinajumi
DE69231123D1 (de) Konjugaten von Zell-bindender Mittel und Derivaten von CC-1065
DE69325658D1 (de) Substituierte thiazolidindion derivate
ATA75293A (de) Indolderivate
FR2685328B1 (fr) Derives de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides.
DE69132519D1 (de) Quinolin-Derivate
DE69330497D1 (de) Chinazolin-derivate
MX9201916A (es) Derivados de 4-aril-3-hetero aril ureido quinolina como agentes antihipercolesterolemicos y antiaterosclerosicos.
DE59308714D1 (de) Cyclobutan-benzol-derivate
DE69119185D1 (de) Derivate von Carboxymethyl-Chitin und ihre Verwendung
MA22916A1 (fr) Derives de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides.
NO930520D0 (no) Bifenyl-substituerte kinolinderivater
FR2698359B1 (fr) Derives de 2-alkoxy 2-imidazoline-5-ones fongicides.
DK0483702T3 (da) Impulsbredde-moduleret forstærker
NO952171D0 (no) 3-heteroalifatyl- og 3-hetero(aryl)alifatyl-2(1H)-chinolon-derivater
NO952288D0 (no) Benzazepinon-derivater
FI912963A (fi) Hjaernverksamheten oekande pyrimidinylderivat.
BR9106582A (pt) Derivados de tetrazol e medicamentos
MX9205973A (es) Derivados de benzo-isoquinolinas.
MX9201931A (es) Nuevos derivados de tiazol.
FI934647A (fi) Alkoximetylsubstituerade pyridonbifenyler
FR2682944B1 (fr) Nouveau compose aluminophosphate et ses derives.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees